scholarly article | Q13442814 |
P50 | author | Nicholas L. Mills | Q42405715 |
Marc R Dweck | Q57009695 | ||
James H Rudd | Q57077698 | ||
Alex T Vesey | Q57192011 | ||
Keith Fox | Q72227369 | ||
Iqbal Toor | Q92233789 | ||
William S. Jenkins | Q92678487 | ||
David E Newby | Q94451652 | ||
Neal Uren | Q114309800 | ||
Shirjel R Alam | Q116781999 | ||
P2093 | author name string | Anoop S V Shah | |
Edwin J R van Beek | |||
Alison M Fletcher | |||
Nikhil V Joshi | |||
Adam J Melville | |||
Andrew Sills | |||
Kathryn Carruthers | |||
Sarah P Langlands | |||
Teng Y Hoo | |||
P2860 | cites work | Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) | Q22242088 |
Identification of splenic reservoir monocytes and their deployment to inflammatory sites | Q24649151 | ||
Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions | Q33916802 | ||
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial | Q34120778 | ||
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. | Q34132798 | ||
Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice. | Q34188766 | ||
Third universal definition of myocardial infarction | Q34295914 | ||
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure | Q34322056 | ||
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. | Q35552554 | ||
Myocardial infarction accelerates atherosclerosis. | Q36106602 | ||
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction | Q36172904 | ||
The incidence of stroke after myocardial infarction: a meta-analysis | Q36431878 | ||
Mechanisms of acute coronary syndromes and their implications for therapy | Q38108628 | ||
Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. | Q38481051 | ||
Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events | Q38495624 | ||
Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide | Q39152434 | ||
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial | Q39315993 | ||
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology | Q39627320 | ||
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease | Q39946694 | ||
A prospective natural-history study of coronary atherosclerosis | Q41983924 | ||
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. | Q42124769 | ||
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina | Q43098198 | ||
Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? | Q43862047 | ||
Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction | Q44237939 | ||
Ischemic stroke after acute myocardial infarction. A population-based study | Q44427240 | ||
Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. | Q46000195 | ||
C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings | Q46627635 | ||
Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). | Q46637686 | ||
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling | Q47785069 | ||
ST elevation acute myocardial infarction accelerates non-culprit coronary lesion atherosclerosis. | Q51328588 | ||
Multiple Complex Coronary Plaques in Patients with Acute Myocardial Infarction | Q56775151 | ||
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006 | Q57243464 | ||
Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list | Q57243537 | ||
Preventive Angioplasty in Myocardial Infarction | Q58133716 | ||
C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction | Q73606387 | ||
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients | Q79328884 | ||
Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery | Q79734262 | ||
Percutaneous coronary intervention for late reperfusion after myocardial infarction in stable patients | Q79949667 | ||
Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study | Q84330186 | ||
Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality | Q84588574 | ||
Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging | Q87218257 | ||
P433 | issue | 9 | |
P921 | main subject | myocardial infarction | Q12152 |
atherosclerosis | Q12252367 | ||
acute myocardial infarction | Q18558122 | ||
P304 | page(s) | e001956 | |
P577 | publication date | 2015-08-27 | |
P1433 | published in | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | Q19880670 |
P1476 | title | Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction | |
P478 | volume | 4 |
Q38660995 | A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases |
Q59811795 | A novel fluorescein-bisphosphonate based diagnostic tool for the detection of hydroxyapatite in both cell and tissue models |
Q38874840 | Air pollution and short-term clinical outcomes of patients with acute myocardial infarction |
Q99709769 | Association of glucose uptake of visceral fat and acute myocardial infarction: a pilot 18F-FDG PET/CT study |
Q59133072 | C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up |
Q89574926 | Characterization of glucose uptake metabolism in visceral fat by 18 F-FDG PET/CT reflects inflammatory status in metabolic syndrome |
Q89798553 | Clinical imaging of cardiovascular inflammation |
Q52912755 | Editorial : Scoring and Other Assessments of Plaque Morphology and Pathology |
Q90577485 | Greater aortic inflammation and calcification in abdominal aortic aneurysmal disease than atherosclerosis: a prospective matched cohort study |
Q90455308 | Hepato-splenic axis: hepatic and splenic metabolic activities are linked |
Q64056942 | IL-7R blockade reduces post-myocardial infarction-induced atherosclerotic plaque inflammation in ApoE−/- mice |
Q45793264 | Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study |
Q26764836 | Imaging Atherosclerosis |
Q53028581 | Imaging biomarkers in the clinic. |
Q38844535 | Imaging of coronary atherosclerosis - evolution towards new treatment strategies |
Q92678491 | In vivo alpha-V beta-3 integrin expression in human aortic atherosclerosis |
Q64066315 | Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction |
Q92859238 | Inflammation in atherosclerotic cardiovascular disease |
Q60306046 | Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction |
Q58592672 | Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3) |
Q51730474 | New methods to image unstable atherosclerotic plaques. |
Q37082503 | Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis |
Q26750798 | PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology |
Q37050963 | Positron emission tomography imaging of coronary atherosclerosis |
Q91893037 | Rosuvastatin Prevents the Exacerbation of Atherosclerosis in Ligature-Induced Periodontal Disease Mouse Model |
Q92305993 | Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction |
Q91599400 | miR-499 released during myocardial infarction causes endothelial injury by targeting α7-nAchR |
Search more.